As they shift from pediatric to adult care, young adult patients with sickle cell disease appear to visit the ER more often, ...
This article is part of a Health Affairs Forefront series on “The Future of Sickle Cell Disease Research and Care” with support from the American Society of Hematology. The articles in the series are ...
Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of patients were able to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results